Board of Directors - Treatment Research Institute

Board of Directors

The Treatment Research Institute is governed by a nine-member Board of experts in substance abuse and related fields.

Carolyn Asbury PhD Board Chair Carolyn Asbury, ScMPH, PhD, Board Chair, is Senior Consultant at the Dana Foundation, where she supports clinical research in immunology and in neuroscience, including addiction. She is also Senior Fellow of the University of Pennsylvania’s Leonard Davis Institute where she conducts research on orphan medical drugs. Dr. Asbury is formerly of The Robert Wood Johnson Foundation and a former Director of The Pew Charitable Trusts’ Health and Human Services Program.

Biography Carolyn Asbury, ScMPH, PhD, Board Chair, is Senior Consultant at the Dana Foundation, where she supports clinical research in immunology and in neuroscience, including addiction. She is also Senior Fellow of the University of Pennsylvania’s Leonard Davis Institute where she conducts research on orphan medical drugs. Dr. Asbury is formerly of The Robert Wood Johnson Foundation and a former Director of The Pew Charitable Trusts’ Health and Human Services Program.

Mary Esteves MEd Mary Esteves, MEd is President of Nova Consulting, Inc., an organization that helps well-run firms become extraordinary companies based on over 30 years of management and organizational consulting to heads of major corporations. A counseling psychologist with extensive management experience, Ms. Esteves is dedicated to helping executives attain excellence in their marketplace by optimizing their leadership and employee talent for greater productivity and profitability. Her expertise in organizational and job competency assessment; motivation and management training; and career planning, appraisal and development, spans national and international markets ranging from pharmaceutical, chemical, transportation and consumer products to telecommunication, computer, financial and advertising. Other distinguished consulting organizations she has led include Integra Consulting (President), a research-based organization dedicated to improving individual, group and organizational functioning; the Hay Group (Owner-Partner and Managing Director of its North and South America Human Resources Planning and Development Business Unit), dedicated to helping public and private sector groups attain competitive advantage through selection, appraisal and development of human resources; and McBer and Company (Officer and Senior Vice President) where she helped clients in numerous industries reduce product development cycle time and improve bottom-line results. A published author on entrepreneurial innovation, organizational competencies, life and career planning, goal setting, values clarification, and organizational effectiveness for women, Ms. Esteves has also served as a psychologist and consultant to a community hospital and social services agency. She holds a Master’s Degree in Counseling Psychology and has pursued advanced education with National Training Laboratories and the Institute of Social Research at the University of Michigan, among other institutions.

Biography Mary Esteves, MEd is President of Nova Consulting, Inc., an organization that helps well-run firms become extraordinary companies based on over 30 years of management and organizational consulting to heads of major corporations. A counseling psychologist with extensive management experience, Ms. Esteves is dedicated to helping executives attain excellence in their marketplace by optimizing their leadership and employee talent for greater productivity and profitability. Her expertise in organizational and job competency assessment; motivation and management training; and career planning, appraisal and development, spans national and international markets ranging from pharmaceutical, chemical, transportation and consumer products to telecommunication, computer, financial and advertising. Other distinguished consulting organizations she has led include Integra Consulting (President), a research-based organization dedicated to improving individual, group and organizational functioning; the Hay Group (Owner-Partner and Managing Director of its North and South America Human Resources Planning and Development Business Unit), dedicated to helping public and private sector groups attain competitive advantage through selection, appraisal and development of human resources; and McBer and Company (Officer and Senior Vice President) where she helped clients in numerous industries reduce product development cycle time and improve bottom-line results. A published author on entrepreneurial innovation, organizational competencies, life and career planning, goal setting, values clarification, and organizational effectiveness for women, Ms. Esteves has also served as a psychologist and consultant to a community hospital and social services agency. She holds a Master’s Degree in Counseling Psychology and has pursued advanced education with National Training Laboratories and the Institute of Social Research at the University of Michigan, among other institutions.

Mathea Falco Esq. Mathea Falco, Esq. is President of Drug Strategies, a nonprofit research institute that identifies effective approaches to substance abuse. The author of The Making of a Drug-Free America: Programs That Work, Ms. Falco comments frequently on drug policy in the media and in public speeches across the country. Until 1993, she was Director of Health Policy, Department of Public Health, Cornell University Medical College in New York City. From 1977 to 1981, Ms. Falco was Assistant Secretary of State for International Narcotics Matters. In earlier positions, she served as Chief Counsel and Staff Director of the U.S. Senate Judiciary Committee, Juvenile Delinquency Subcommittee, and as Special Assistant to the President of the Drug Abuse Council. Ms. Falco has been a member of the Board of Overseers of Harvard University, a Trustee of Radcliffe College, and the Chair of the Visiting Committee on Harvard University Health Services. She also has served on the national boards of Girl Scouts, USA; Big Brothers of America; the International Women’s Health Coalition, the Ploughshares Fund; and the National Council on Crime and Delinquency. Ms. Falco is a graduate of Radcliffe College and Yale Law School.

Biography Mathea Falco, Esq. is President of Drug Strategies, a nonprofit research institute that identifies effective approaches to substance abuse. The author of The Making of a Drug-Free America: Programs That Work, Ms. Falco comments frequently on drug policy in the media and in public speeches across the country. Until 1993, she was Director of Health Policy, Department of Public Health, Cornell University Medical College in New York City. From 1977 to 1981, Ms. Falco was Assistant Secretary of State for International Narcotics Matters. In earlier positions, she served as Chief Counsel and Staff Director of the U.S. Senate Judiciary Committee, Juvenile Delinquency Subcommittee, and as Special Assistant to the President of the Drug Abuse Council. Ms. Falco has been a member of the Board of Overseers of Harvard University, a Trustee of Radcliffe College, and the Chair of the Visiting Committee on Harvard University Health Services. She also has served on the national boards of Girl Scouts, USA; Big Brothers of America; the International Women’s Health Coalition, the Ploughshares Fund; and the National Council on Crime and Delinquency. Ms. Falco is a graduate of Radcliffe College and Yale Law School.

Y. Jae Kim Esq. Y. Jae Kim, Esq. is an intellectual property attorney with Kim Krizman LLC, a Cherry Hill, NJ intellectual property law firm. Mr. Kim’s practice focuses on patent procurement, patent litigation, and counseling, but extends to licensing, trademarks and copyrights. Prior to joining Kim Krizman LLC, Mr. Kim was an intellectual property attorney at Panitch Schwarze Belisario & Nadel, and Akin Gump Strauss Hauer & Feld (both in Philadelphia, PA) and Darby & Darby in New York. He also has over a decade of experience working in the medical device industry designing, developing, and managing medical device products worldwide. Mr. Kim received his B.S. in chemical engineering and J.D. from Rutgers University, and is a member of the New York, New Jersey, and Pennsylvania State Bars.

Biography Y. Jae Kim, Esq. is an intellectual property attorney with Kim Krizman LLC, a Cherry Hill, NJ intellectual property law firm. Mr. Kim’s practice focuses on patent procurement, patent litigation, and counseling, but extends to licensing, trademarks and copyrights. Prior to joining Kim Krizman LLC, Mr. Kim was an intellectual property attorney at Panitch Schwarze Belisario & Nadel, and Akin Gump Strauss Hauer & Feld (both in Philadelphia, PA) and Darby & Darby in New York. He also has over a decade of experience working in the medical device industry designing, developing, and managing medical device products worldwide. Mr. Kim received his B.S. in chemical engineering and J.D. from Rutgers University, and is a member of the New York, New Jersey, and Pennsylvania State Bars.

Herbert D. Kleber MD Herbert D. Kleber, MD is Professor of Psychiatry and Director of the Division on Substance Abuse at the Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute. Until 2001, he was Executive Vice-President and Medical Director of the National Center on Addiction and Substance Abuse (CASA), a policy center he and Joseph Califano founded in 1992. He previously served for more than two years as the Deputy Director for Demand Reduction at the Office of National Drug Control Policy in the White House. He has received numerous awards, is listed as one of the “Best Doctors in America” and “Best Doctors in New York,” was elected in 1996 to The Institute of Medicine of the National Academy of Science, and serves on the National Advisory Council to the National Institute on Drug Abuse.

Biography Herbert D. Kleber, MD is Professor of Psychiatry and Director of the Division on Substance Abuse at the Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute. Until 2001, he was Executive Vice-President and Medical Director of the National Center on Addiction and Substance Abuse (CASA), a policy center he and Joseph Califano founded in 1992. He previously served for more than two years as the Deputy Director for Demand Reduction at the Office of National Drug Control Policy in the White House. He has received numerous awards, is listed as one of the “Best Doctors in America” and “Best Doctors in New York,” was elected in 1996 to The Institute of Medicine of the National Academy of Science, and serves on the National Advisory Council to the National Institute on Drug Abuse.

Kenneth A. Lynch CPA, MT Kenneth A. Lynch, CPA, MT is Assistant Vice President for Financial Reporting and Risk Management at South Jersey Industries, Inc. He has 20 years of experience performing assurance services and advising companies on complex financial issues. Formerly a Senior Manager in the Entrepreneurial Services Group of Ernst and Young LLP, Ken has served a wide range of clients from closely held, emerging growth companies to multi-national, publicly traded entities. These clients have primarily been in the manufacturing, retail, distribution, software, service and technology industries. Ken has assisted numerous clients as they enter into significant transactions such as mergers, acquisitions and public offerings.

Biography Kenneth A. Lynch, CPA, MT is Assistant Vice President for Financial Reporting and Risk Management at South Jersey Industries, Inc. He has 20 years of experience performing assurance services and advising companies on complex financial issues. Formerly a Senior Manager in the Entrepreneurial Services Group of Ernst and Young LLP, Ken has served a wide range of clients from closely held, emerging growth companies to multi-national, publicly traded entities. These clients have primarily been in the manufacturing, retail, distribution, software, service and technology industries. Ken has assisted numerous clients as they enter into significant transactions such as mergers, acquisitions and public offerings.

Charles P. O’Brien MD, PhD Charles P. O’Brien, MD, PhD is Chief of Psychiatry at the Philadelphia VA Medical Center, and Vice-Chair of Psychiatry at the University of Pennsylvania where he is also Director of the Center for Studies of Addiction. O’Brien was elected to the Institute of Medicine of the National Academy of Sciences in 1991, and has received numerous national research awards as well as an honorary Doctorate from the University of Bordeaux in 1994 and the Nathan P. Eddy award for research on addiction from the College on Problems of Drug Dependence. O’Brien’s research focus is on discovery of changes to the central nervous system involved in relapse, new medications, behavioral treatments, and instruments for measuring the severity of addictive disorders. He is past President of both the American College of Neuropsychopharmacology and the Association for Research in Nervous and Mental Disease.

Biography Charles P. O’Brien, MD, PhD is Chief of Psychiatry at the Philadelphia VA Medical Center, and Vice-Chair of Psychiatry at the University of Pennsylvania where he is also Director of the Center for Studies of Addiction. O’Brien was elected to the Institute of Medicine of the National Academy of Sciences in 1991, and has received numerous national research awards as well as an honorary Doctorate from the University of Bordeaux in 1994 and the Nathan P. Eddy award for research on addiction from the College on Problems of Drug Dependence. O’Brien’s research focus is on discovery of changes to the central nervous system involved in relapse, new medications, behavioral treatments, and instruments for measuring the severity of addictive disorders. He is past President of both the American College of Neuropsychopharmacology and the Association for Research in Nervous and Mental Disease.

Stephen J. Pasierb MEd Stephen J. Pasierb, MEd, is President and CEO of The Partnership at Drugfree.org. He leads a research-based, public health nonprofit whose mission is to help parents prevent, intervene in and find treatment for drug and alcohol use by their children. He is a frequent commentator in national and local news media and in Washington, DC on issues including the changing landscape of drug and alcohol use in America, effective prevention strategies for families and the role/value of addiction treatment and recovery. In the eight years prior to becoming President, Steve directed the nonprofit’s State/City Alliance Program which forms public-private partnerships to operate comprehensive drug abuse prevention programs. Steve holds a M.Ed. degree with honors in Communications Media and a B.S. in Criminology. He is a member of the national Honor Society of Phi Kappa Phi for scholarly distinction.

Biography Stephen J. Pasierb, MEd, is President and CEO of The Partnership at Drugfree.org. He leads a research-based, public health nonprofit whose mission is to help parents prevent, intervene in and find treatment for drug and alcohol use by their children. He is a frequent commentator in national and local news media and in Washington, DC on issues including the changing landscape of drug and alcohol use in America, effective prevention strategies for families and the role/value of addiction treatment and recovery. In the eight years prior to becoming President, Steve directed the nonprofit’s State/City Alliance Program which forms public-private partnerships to operate comprehensive drug abuse prevention programs. Steve holds a M.Ed. degree with honors in Communications Media and a B.S. in Criminology. He is a member of the national Honor Society of Phi Kappa Phi for scholarly distinction.

George E. Woody MD George E. Woody, MD is a Professor in the Department of Psychiatry at the University of Pennsylvania with 35 years of specialized research on treatment efficacy in substance abuse. Among his notable achievements are founding member of the Board of Addiction Psychiatry of the American Psychiatric Association, two-time member of the Board of Directors of the College on Problems of Drug Dependence, and Life Fellow of the American Psychiatric Association. He is currently Director of the Delaware Valley Node of the NIDA-funded Clinical Trials Network.

Biography George E. Woody, MD is a Professor in the Department of Psychiatry at the University of Pennsylvania with 35 years of specialized research on treatment efficacy in substance abuse. Among his notable achievements are founding member of the Board of Addiction Psychiatry of the American Psychiatric Association, two-time member of the Board of Directors of the College on Problems of Drug Dependence, and Life Fellow of the American Psychiatric Association. He is currently Director of the Delaware Valley Node of the NIDA-funded Clinical Trials Network.